SmPC - Etoposide 20mg/ml Concentrate for Solution for Infusion: Change history
View Summary of Product Characteristics (SmPC - Etoposide 20mg/ml Concentrate for Solution for Infusion)
Last updated on this site: 13 Feb 2024
Description of update: Update to section 4.4 and 4.8 of the SmPC and section 4 of the PIL to implement the wording agreed by PRAC following the outcome of the PSUR procedure PSUSA/00001333/202302.
SmPC Sections updated: 4.4, 4.8 and 10.
Last updated on this site: 13 Feb 2024
Description of update: Update to section 4.4 and 4.8 of the SmPC and section 4 of the PIL to implement the wording agreed by PRAC following the outcome of the PSUR procedure PSUSA/00001333/202302.
SmPC Sections updated: 4.4, 4.8 and 10.
-
Changes: (Updated: 13 Feb 2024)
Description of update: Update to section 4.4 and 4.8 of the SmPC and section 4 of the PIL to implement the wording agreed by PRAC following the outcome of the PSUR procedure PSUSA/00001333/202302.
SmPC Sections updated: 4.4, 4.8 and 10.
-
Changes: (Updated: 08 Feb 2023)
To register an update to sections 4.2, 4.4 and 4.8 of the SPC in line with reference product (Etopophos 100 mg/1000mg powder for solution for infusion). Consequentially, the leaflet has been updated.
-
Changes: (Updated: 30 Dec 2022)
To update SmPC and PIL information in-line with reference product.
-
Changes: (Updated: 20 Sep 2022)
Initial upload